FDA Inspection 1181988 — East Coast Infertility and IVF PC
The FDA completed an inspection of East Coast Infertility and IVF PC on October 24, 2022 in Shrewsbury, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 24, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Shrewsbury, NJ (United States)